Cargando…
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of dysregulated lipid and glucose metabolism, which is often associated with obesity, dyslipidemia and insulin resistance. In view of the high morbidity and health risks of NAFLD, the lack of effective cure has drawn great attent...
Autores principales: | Hu, Haiming, Lin, Aizhen, Kong, Mingwang, Yao, Xiaowei, Yin, Mingzhu, Xia, Hui, Ma, Jun, Liu, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981320/ https://www.ncbi.nlm.nih.gov/pubmed/31845054 http://dx.doi.org/10.1007/s00535-019-01649-8 |
Ejemplares similares
-
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019) -
Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives
por: Fotis, Dimitrios, et al.
Publicado: (2022) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018) -
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD
por: Smirnova, Ekaterina, et al.
Publicado: (2022) -
Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
por: Liu, Jianjun, et al.
Publicado: (2023)